ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ
Earnings Release
Shareholders Elect 11 Directors at Bristol-Myers Squibb Annual Meeting
Reports First Quarter Financial Results for 2026
Annual Report to Security Holders
Reports Fourth Quarter and Full-Year Financial Results for 2025
Investor Presentation
Announces Accepted Amounts and Pricing Terms of its Tender Offers
Bristol-Myers Squibb Completes €4.8 Billion Public Offering of Notes
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Notice of Suspension of Duty to File Reports
Certificate
Registration of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus Filed Pursuant to Rule 424(b)(2)
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Automatic Shelf Registration Statement
Amended Tender Offer Statement by Third Party